Analysis of EV71 infection progression using triple-SILAC-based proteomics approach

Proteomics

Volumn 15, Issue 21, 2015, Pages 3629-3643

  Li, Hao Yu ^a   Zhang, Lei Ke ^b   Zhu, Xiu Juan ^a   Shang, Jun ^a   Chen, Xi ^c   Zhu, Ying ^a   Guo, Lin ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c Wuhan Institute of Technoloy   (China)

Author keywords

Cell biology; CHCH2; Enterovirus 71; Picornaviridae; Triple SILAC

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL PROTEIN; PROTEOME;

ARTICLE; CONTROLLED STUDY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; INNATE IMMUNITY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; WESTERN BLOTTING; CELL LINE; DISEASE COURSE; ENTEROVIRUS A; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

CELL LINE; DISEASE PROGRESSION; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; PROTEOME; PROTEOMICS;

EID: 84945122923     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500180     Document Type: Article

References (82)

1. Schmidt, N. J., Lennette, E. H., Ho, H. H., An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974, 129, 304-309.
2. Solomon, T., Lewthwaite, P., Perera, D., Cardosa, M. J. et al., Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010, 10, 778-790.
3. Ooi, M. H., Wong, S. C., Lewthwaite, P., Cardosa, M. J., Solomon, T., Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010, 9, 1097-1105.
4. Lin, J. Y., Chen, T. C., Weng, K. F., Chang, S. C. et al., Viral and host proteins involved in picornavirus life cycle. J. Biomed. Sci. 2009, 16, 103.
5. Lin, J. Y., Li, M. L., Huang, P. N., Chien, K. Y. et al., Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5' untranslated region and participates in virus replication. J. Gen. Virol. 2008, 89, 2540-2549.
6. Lin, J. Y., Li, M. L., Shih, S. R., Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 2008, 37, 47-59.
7. Thompson, A. P., Noueiry, A. O., Lee, W. M., Kushner, D. B., Dye, B. T., Host factors in positive-strand RNA virus genome replication. J. Virol. 2003, 77, 8181-8186.
8. Wang, J., Du, J., Wu, Z., Jin, Q., Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites. PLoS One 2013, 8, e52954.
9. Shih, S. R., Stollar, V., Li, M. L., Host factors in enterovirus 71 replication. J. Virol. 2011, 85, 9658-9666.
10. McMinn, P. C., Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr. Opin. Virol. 2012, 2, 199-205.
11. Yang, S. L., Chou, Y. T., Wu, C. N., Ho, M. S., Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J. Virol. 2011, 85, 11809-11820.
12. Yang, B., Chuang, H., Yang, K. D., Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 2009, 6, 141.
13. Yamayoshi, S., Yamashita, Y., Li, J., Hanagata, N. et al., Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 2009, 15, 798-801.
14. Tan, C. W., Poh, C. L., Sam, I. C., Chan, Y. F., Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 2013, 87, 611-620.
15. Nishimura, Y., Shimojima, M., Tano, Y., Miyamura, T. et al., Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 2009, 15, 794-797.
16. Nishimura, Y., Shimizu, H., Cellular receptors for human enterovirus species a. Front. Microbiol. 2012, 3, 105.
17. Du, N., Cong, H., Tian, H., Zhang, H. et al., Cell surface vimentin is an attachment receptor for enterovirus 71. J. Virol. 2014, 88, 5816-5833.
18. Nagy, P. D., Pogany, J., The dependence of viral RNA replication on co-opted host factors. Nat. Rev. Microbiol. 2012, 10, 137-149.
19. Chase, A. J., Daijogo, S., Semler, B. L., Inhibition of poliovirus-induced cleavage of cellular protein PCBP2 reduces the levels of viral RNA replication. J. Virol. 2013, 88, 3192-3201.
20. Ilnytska, O., Santiana, M., Hsu, N. Y., Du, W. L. et al., Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe 2013, 14, 281-293.
21. Domingo, E., Weng, K.-F., Li, M.-L., Hung, C.-T., Shih, S.-R., Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Path. 2009, 5, e1000593.
22. Chen, L. L., Kung, Y. A., Weng, K. F., Lin, J. Y. et al., Enterovirus 71 infection cleaves a negative regulator for viral internal ribosomal entry site-driven translation. J. Virol. 2013, 87, 3828-3838.
23. Diamond, D. L., Syder, A. J., Jacobs, J. M., Sorensen, C. M. et al., Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 2010, 6, e1000719.
24. Mannova, P., Fang, R., Wang, H., Deng, B. et al., Modification of host lipid raft proteome upon hepatitis C virus replication. Mol. Cell. Proteomics 2006, 5, 2319-2325.
25. Pando-Robles, V., Oses-Prieto, J. A., Rodriguez-Gandarilla, M., Meneses-Romero, E. et al., Quantitative proteomic analysis of Huh-7 cells infected with Dengue virus by label-free LC-MS. J. Proteomics 2014, 111, 16-29.
26. Pastorino, B., Boucomont-Chapeaublanc, E., Peyrefitte, C. N., Belghazi, M. et al., Identification of cellular proteome modifications in response to West Nile virus infection. Mol. Cell. Proteomics 2009, 8, 1623-1637.
27. Zhang, L. K., Chai, F., Li, H. Y., Xiao, G., Guo, L., Identification of host proteins involved in Japanese encephalitis virus infection by quantitative proteomics analysis. J. Proteome Res. 2013, 12, 2666-2678.
28. Antrobus, R., Grant, K., Gangadharan, B., Chittenden, D. et al., Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome. Proteomics 2009, 9, 3913-3927.
29. Du, G., Stinski, M. F., Interaction network of proteins associated with human cytomegalovirus IE2-p86 protein during infection: a proteomic analysis. PLoS One 2013, 8, e81583.
30. Gkiafi, Z., Panayotou, G., Comparative proteomic analysis implicates COMMD proteins as Epstein-Barr virus targets in the BL41 Burkitt's lymphoma cell line. J. Proteome Res. 2011, 10, 2959-2968.
31. Lin, A. E., Greco, T. M., Dohner, K., Sodeik, B., Cristea, I. M., A proteomic perspective of inbuilt viral protein regulation: pUL46 tegument protein is targeted for degradation by ICP0 during herpes simplex virus type 1 infection. Mol. Cell. Proteomics 2013, 12, 3237-3252.
32. O'Connor, C. M., DiMaggio, P. A., Jr., Shenk, T., Garcia, B. A., Quantitative proteomic discovery of dynamic epigenome changes that control human cytomegalovirus (HCMV) infection. Mol. Cell. Proteomics 2014, 13, 2399-2410.
33. Britton, L. M., Sova, P., Belisle, S., Liu, S. et al., A proteomic glimpse into the initial global epigenetic changes during HIV infection. Proteomics 2014, 14, 2226-2230.
34. Huang, X., Stone, D. K., Yu, F., Zeng, Y., Gendelman, H. E., Functional proteomic analysis for regulatory T cell surveillance of the HIV-1-infected macrophage. J. Proteome Res. 2010, 9, 6759-6773.
35. Schweitzer, C. J., Jagadish, T., Haverland, N., Ciborowski, P., Belshan, M., Proteomic analysis of early HIV-1 nucleoprotein complexes. J. Proteome Res. 2013, 12, 559-572.
36. Nuss, J. E., Kehn-Hall, K., Benedict, A., Costantino, J. et al., Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors. PLoS One 2014, 9, e93483.
37. Liu, Y., Wang, X., Li, S., Hu, H. et al., The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study. J. Proteomics 2014, 106, 99-112.
38. Ma, Y., Yu, J., Chan, H. L., Chen, Y. C. et al., Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol. Cell. Proteomics 2009, 8, 2582-2594.
39. Xie, N., Huang, K., Zhang, T., Lei, Y. et al., Comprehensive proteomic analysis of host cell lipid rafts modified by HBV infection. J. Proteomics 2012, 75, 725-739.
40. Zhang, T., Xie, N., He, W., Liu, R. et al., An integrated proteomics and bioinformatics analyses of hepatitis B virus X interacting proteins and identification of a novel interactor apoA-I. J. Proteomics 2013, 84, 92-105.
41. Bradel-Tretheway, B. G., Mattiacio, J. L., Krasnoselsky, A., Stevenson, C. et al., Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors. J. Virol. 2011, 85, 8569-8581.
42. Dove, B. K., Surtees, R., Bean, T. J., Munday, D. et al., A quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza A virus using stable isotope labelling with amino acids in cell culture. Proteomics 2012, 12, 1431-1436.
43. Kroeker, A. L., Ezzati, P., Halayko, A. J., Coombs, K. M., Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study. J. Proteome Res. 2012, 11, 4132-4146.
44. Lietzen, N., Ohman, T., Rintahaka, J., Julkunen, I. et al., Quantitative subcellular proteome and secretome profiling of influenza A virus-infected human primary macrophages. PLoS Pathog. 2011, 7, e1001340.
45. Lee, J. J., Seah, J. B. K., Chow, V. T. K., Poh, C. L., Tan, E. L., Comparative proteome analyses of host protein expression in response to Enterovirus 71 and Coxsackievirus A16 infections. J. Proteomics 2011, 74, 2018-2024.
46. Leong, W. F., Chow, V. T. K., Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection. Cell. Microbiol. 2006, 8, 565-580.
47. Xu, L. J., Jiang, T., Zhang, F. J., Han, J. F. et al., Global transcriptomic analysis of human neuroblastoma cells in response to enterovirus type 71 infection. PLoS One 2013, 8, e65948.
48. Lui, Y. L., Tan, T. L., Timms, P., Hafner, L. M. et al., Elucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profiling. FEBS Open Bio. 2014, 4, 426-431.
49. Kuo, R. L., Lin, Y. H., Wang, R. Y., Hsu, C. W. et al., Proteomics analysis of EV71-infected cells reveals the involvement of host protein NEDD4L in EV71 replication. J. Proteome Res. 2015, 14, 1818-1830.
50. Emmott, E., Goodfellow, I., Identification of protein interaction partners in mammalian cells using SILAC-immunoprecipitation quantitative proteomics. J. Vis. Exp. 2014.
51. Kuo, R. L., Kao, L. T., Lin, S. J., Wang, R. Y., Shih, S. R., MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One 2013, 8, e63431.
52. Coyne, C. B., Wang, B., Xi, X., Lei, X. et al., Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Path. 2013, 9, e1003231.
53. Lu, J., Yi, L., Zhao, J., Yu, J. et al., Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012, 86, 3767-3776.
54. Mi, H., Muruganujan, A., Casagrande, J. T., Thomas, P. D., Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 2013, 8, 1551-1566.
55. Engdahl, C., Naslund, J., Lindgren, L., Ahlm, C., Bucht, G., The Rift Valley fever virus protein NSm and putative cellular protein interactions. Virol. J. 2012, 9, 139.
56. Mukherjee, P., Woods, T. A., Moore, R. A., Peterson, K. E., Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death. Immunity 2013, 38, 705-716.
57. Bartosch, B., Vitelli, A., Granier, C., Goujon, C. et al., Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 2003, 278, 41624-41630.
58. Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M. et al., The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002, 21, 5017-5025.
59. Aras, S., Pak, O., Sommer, N., Finley, R., Jr. et al., Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2. Nucleic Acids Res. 2013, 41, 2255-2266.
60. Aras, S., Bai, M., Lee, I., Springett, R. et al., MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism. Mitochondrion 2014, 20C, 43-51.
61. Huang, P. N., Shih, S. R., Update on enterovirus 71 infection. Curr. Opin. Virol. 2014, 5, 98-104.
62. Jacobs, J. L., Coyne, C. B., Mechanisms of MAVS regulation at the mitochondrial membrane. J. Mol. Biol. 2013, 425, 5009-5019.
63. Lei, X., Liu, X., Ma, Y., Sun, Z. et al., The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and Type I interferon responses. J. Virol. 2010, 84, 8051-8061.
64. Lei, C. Q., Zhang, Y., Xia, T., Jiang, L. Q. et al., FoxO1 negatively regulates cellular antiviral response by promoting degradation of IRF3. J. Biol. Chem. 2013, 288, 12596-12604.
65. Seth, R. B., Sun, L., Ea, C.-K., Chen, Z. J., Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 2005, 122, 669-682.
66. Yang, Y., Liao, B., Wang, S., Yan, B. et al., E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation. Proc. Natl. Acad. Sci. U S A 2013, 110, 5115-5120.
67. Falk, M. M., Grigera, P. R., Bergmann, I. E., Zibert, A. et al., Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J. Virol. 1990, 64, 748-756.
68. Wimmer, P., Schreiner, S., Dobner, T., Human pathogens and the host cell SUMOylation system. J. Virol. 2012, 86, 642-654.
69. Chen, S. C., Chang, L. Y., Wang, Y. W., Chen, Y. C. et al., Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis. J. Biol. Chem. 2011, 286, 31373-31384.
70. Gomes, R., Guerra-Sa, R., Arruda, E., Coxsackievirus B5 induced apoptosis of HeLa cells: effects on p53 and SUMO. Virology 2010, 396, 256-263.
71. Buschmann, T., Fuchs, S. Y., Lee, C. G., Pan, Z. Q., Ronai, Z., SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 2000, 101, 753-762.
72. Jin, X., Jin, H. R., Jung, H. S., Lee, S. J. et al., An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitination. J. Biol. Chem. 2010, 285, 30539-30547.
73. Matheny, S. A., Chen, C., Kortum, R. L., Razidlo, G. L. et al., Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 2004, 427, 256-260.
74. Cao, R., Tsukada, Y., Zhang, Y., Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 2005, 20, 845-854.
75. Yan, Q., Dutt, S., Xu, R., Graves, K. et al., BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response. Mol. Cell 2009, 36, 110-120.
76. Ohzono, C., Etoh, S., Matsumoto, M., Nakayama, K. I. et al., Nedd4-interacting protein 2, a short half-life membrane protein degraded in lysosomes, negatively controls down-regulation of connexin43. Biol. Pharm. Bull. 2010, 33, 951-957.
77. Pirozzi, G., McConnell, S. J., Uveges, A. J., Carter, J. M. et al., Identification of novel human WW domain-containing proteins by cloning of ligand targets. J. Biol. Chem. 1997, 272, 14611-14616.
78. Anand, S. K., Tikoo, S. K., Viruses as modulators of mitochondrial functions. Adv. Virol. 2013, 2013, 738794.
79. Claus, C., Liebert, U. G., A renewed focus on the interplay between viruses and mitochondrial metabolism. Arch. Virol. 2014, 159, 1267-1277.
80. Lei, C. Q., Zhang, Y., Li, M., Jiang, L. Q. et al., ECSIT bridges RIG-I-like receptors to VISA in signaling events of innate antiviral responses. J. Innate Immun. 2015, 7, 153-164.
81. Li, J., Li, Y., Qin, D., vonHarsdorf, R., Li, P., Mitochondrial fission leads to Smac/DIABLO release quenched by ARC. Apoptosis 2010, 15, 1187-1196.
82. Vizcaíno, J.A., Deutsch, E.W., Wang, R., Csordas, A., ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 2014, 30, 223-226.